Ursodeoxycholic Acid Cuts SARS-CoV-2 Infection, Severity
Ursodeoxycholic acid exposure among participants with cirrhosis tied to reduced odds of developing SARS-CoV-2 infection.
Stay updated with breaking news from Binuv John. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Ursodeoxycholic acid exposure among participants with cirrhosis tied to reduced odds of developing SARS-CoV-2 infection.
MONDAY, April 10, 2023 (HealthDay News) -- Ursodeoxycholic acid (UDCA) is associated with a reduction in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and COVID-19 severity in patients with
Cirrhosis of the liver is associated with decreased responsiveness to many vaccines, including those that protect against COVID-19.
Among cirrhosis patients, receiving a third dose of the vaccine was associated with an 80 per cent reduction in overall Covid-19 and a 100 per cent reduction in the severe course of the infection or death, says a new report.The study, published ...
SAN DIEGO — Vaccine-induced immunity correlated with significantly greater protection against COVID-19 compared with infection-induced immunity in patients with cirrhosis, according to results presented at Digestive Disease Week 2022. “Immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can be infection- or vaccine-induced,” Binu V. John, MD, MPH, affiliate